Transfemoral balloon angioplasty of severe coarctation of aorta in 1200 g newborn

Garg, Gaurav; Goyal, Naresh Kumar; Mandhan, Gaurav; Sidana, Poonam

doi:10.4103/0974-2069.197047

Cited by 4 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In selected cases, balloon angioplasty may be performed as a palliative strategy to stabilize neonates unable to undergo urgent surgical treatment due to severe clinical impairment [ 5 , 70 ]. Although the percutaneous treatment of aortic coarctation in neonates and infants remains controversial due to the occurrence of residual or recurrent stenosis and aneurysm formation at the dilation site [ 71 ], urgent balloon dilation can diminish mortality rates, providing a bridge to surgery for severely ill patients [ 23 , 72 ].…”

Section: Aortic Coarctationmentioning

confidence: 99%

Transcatheter Interventions for Neonates with Congenital Heart Disease: A Review

Meliota

Vairo

2023

Diagnostics

View full text Add to dashboard Cite

Newborns with congenital heart disease often require interventions linked to high morbidity and mortality rates. In the last few decades, many transcatheter interventions have become the first-line treatments for some critical conditions in the neonatal period. A catheter-based approach provides several advantages in terms of procedural time, length of hospitalization, repeatability and neurodevelopmental issues (usually related to cardiopulmonary bypass). The main transcatheter procedures will be reviewed, as they are now valid alternatives to conventional surgical management.

show abstract

Section: Aortic Coarctationmentioning

confidence: 99%

Transcatheter Interventions for Neonates with Congenital Heart Disease: A Review

Meliota

Vairo

2023

Diagnostics

View full text Add to dashboard Cite

show abstract

“…In specific cases where neonates are too clinically compromised to undergo immediate surgical intervention, balloon angioplasty emerges as a palliative measure to stabilize their condition [39,40]. Nonetheless, the percutaneous treatment of aortic coarctation in neonates and infants remains contentious due to concerns surrounding residual or recurrent stenosis and the potential formation of aneurysms at the dilation site [41].…”

Section: Balloon Angioplastymentioning

confidence: 99%

From Crafoord’s End-to-End Anastomosis Approach to Percutaneous Interventions: Coarctation of the Aorta Management Strategies and Reinterventions

Vasile,

Laforest,

Bulescu

et al. 2023

JCM

View full text Add to dashboard Cite

First described in 1760 by the anatomist Morgagni, coarctation of the aorta (CoA) is a congenital heart defect characterized by narrowing the aorta, typically distal to the left subclavian artery. It accounts for approximately 5–8% of all congenital heart diseases, with an incidence estimated at 4 per 10,000 live births. In 1944, the Swedish surgeon Clarence Crafoord achieved the first successful surgical CoA repair by performing an aortic end-to-end anastomosis on two patients aged 12 and 27 years old. Presently, the most prevalent techniques for surgical repair, particularly in infants and neonates with isolated coarctation, involve resection with end-to-end anastomosis (EEA) and the modified Crafoord technique (extended resection with end-to-end anastomosis (EEEA)). Subclavian flap aortoplasty (SCAP) is an alternative surgical option for CoA repair in patients under two years of age. In cases where the stenosis extends beyond resection and end-to-end anastomosis feasibility, patch aortoplasty (PP) employing a prosthetic patch can augment the stenotic region, especially for older patients. Despite advances in pediatric cardiology and cardiac surgery, recoarctation remains a significant concern after surgical or interventional repair. This comprehensive review aims to provide a thorough analysis of coarctation management, covering the pioneering techniques introduced by Crafoord using end-to-end anastomosis and now extending to the contemporary era marked by percutaneous interventions as well as the recoarctation rate associated with each type.

show abstract

From Crafoord's End-to-End Anastomosis Approach to Percutaneous Interventions: Coarctation Management Strategies and Reinterventions

Vasile,

Laforest,

Bulescu

et al. 2023

Preprint

View full text Add to dashboard Cite

First described in 1760 by the anatomist Morgagni, CoA is a congenital heart defect characterized by narrowing the aorta, typically distal to the left subclavian artery. It accounts for approximately 5-8% of all congenital heart diseases, with an incidence estimated at 4 per 10,000 live births. In 1944, the Swedish surgeon Clarence Crafoord achieved the first successful surgical CoA repair by performing an aortic end-to-end anastomosis on two patients aged 12 and 27 years old. Presently, the most prevalent techniques for surgical repair, particularly in infants and neonates with isolated coarctation, involve resection with end-to-end anastomosis (EEA) and the modified Crafoord technique (extended resection with end-to-end anastomosis (EEEA)). Subclavian flap aortoplasty (SCAP) is an alternative surgical option for CoA repair in patients under two years of age. In cases where the stenosis extends beyond resection and end-to-end anastomosis feasibility, patch aortoplasty (PP) employing a prosthetic patch can augment the stenotic region, especially for older patients. Despite advances in pediatric cardiology and cardiac surgery, recoarctation remains a significant concern after surgical or interventional repair. This comprehensive review aims to provide a thorough analysis of coarctation management, covering the pioneering techniques introduced by Crafoord using head-to-tail anastomosis and now extending to the contemporary era marked by percutaneous interventions as well as the recoarctation rate associated with each type.

show abstract

Transfemoral balloon angioplasty of severe coarctation of aorta in 1200 g newborn

Cited by 4 publications

References 3 publications

Transcatheter Interventions for Neonates with Congenital Heart Disease: A Review

Transcatheter Interventions for Neonates with Congenital Heart Disease: A Review

From Crafoord’s End-to-End Anastomosis Approach to Percutaneous Interventions: Coarctation of the Aorta Management Strategies and Reinterventions

From Crafoord's End-to-End Anastomosis Approach to Percutaneous Interventions: Coarctation Management Strategies and Reinterventions

Contact Info

Product

Resources

About